Evidence map›Paper›PMID 39771017›Full record

Trial reportNutrients2024

Effect of

Mohammad Rahman Rahimi, Hassan Faraji, Seyyed Rasoul Hajipoor, Ildus I Ahmetov

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammad Rahman RahimiDepartment of Exercise Physiology, University of Kurdistan, Sanandaj 66177-15175, Iran.ORCID 0000-0002-4302-1472
Hassan FarajiDepartment of Physical Education and Sports Science, Marivan Branch, Islamic Azad University, Marivan 14778-93855, Iran.
Seyyed Rasoul HajipoorDepartment of Exercise Physiology, University of Kurdistan, Sanandaj 66177-15175, Iran.
Ildus I AhmetovLaboratory of Genetics of Aging and Longevity, Kazan State Medical University, 420012 Kazan, Russia.ORCID 0000-0002-6335-4020

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe monocarboxylate transporter 1 (MCT1) plays a crucial role in regulating lactate and pyruvate transport across cell membranes, which is essential for energy metabolism during exercise. The

methodsThirty resistance-trained athletes were randomly selected to participate in a randomized, double-blind, placebo-controlled crossover study. Participants consumed either CAF (6 mg/kg of body weight) or a placebo (PL; 6 mg of maltodextrin per kg of body weight) one hour before performing RE. Serum lactate and potassium concentrations were measured before exercise (Pre), immediately after (Post), and 15 min post-exercise (15 min Post). The RE protocol consisted of three sets to failure at 85% of 1RM for each exercise, with 2 min rest intervals between sets.

resultsThe findings indicate that under caffeine consumption, individuals carrying the A (minor) allele had significantly higher blood lactate levels before (

conclusionsOur findings suggest that the

Indexed as

CaffeineCross-Over StudiesLactic AcidMonocarboxylic Acid TransportersPotassiumResistance TrainingSymportersAdultAllelesAthletesDouble-Blind MethodExerciseFemaleGenotypeHumansMaleCaffeineLactic AcidMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersPotassiumSymporterscaffeineDNAgenotypelactatemonocarboxylate transporter 1nutrigeneticsrecoveryresistance exercisesports

Identifiers

PMID39771017
PMCPMC11676378

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.